Ambalal Sarabhai Enterprises Share Price

BSE
AMBASARABH •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Ambalal Sarabhai Enterprises Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
71.28% Gain from 52W Low
-14.4
TTM PE Ratio
Above industry Median
39.8
Price to Book Ratio
Below industry Median
3.4
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is less than 1
0.3

Ambalal Sarabhai Enterprises Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Revenue
QuarterlyYearly
Jun 2024 - 40.6966 Cr Mar 2024 - 183.9452 Cr
Mar 2024 - 54.3458 Cr Mar 2023 - 182.7728 Cr
Dec 2023 - 43.1115 Cr Mar 2022 - 238.7607 Cr
Sep 2023 - 40.0107 Cr Mar 2021 - 194.2225 Cr
Jun 2023 - 36.1025 Cr Mar 2020 - 157.8905 Cr
Net Profit/Loss
QuarterlyYearly
Jun 2024 - 0.7079 Cr Mar 2024 - 8.3922 Cr
Mar 2024 - 10.0958 Cr Mar 2023 - 12.1419 Cr
Dec 2023 - 1.0689 Cr Mar 2022 - 40.7983 Cr
Sep 2023 - 1.1251 Cr Mar 2021 - 20.2415 Cr
Jun 2023 - -3.8976 Cr Mar 2020 - 15.4358 Cr

Ambalal Sarabhai Enterprises Ltd shareholding Pattern

Promoter
31.4%
Public
68.6%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%

Ambalal Sarabhai Enterprises Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
14
Bearish Moving Averages
2
5Day EMA
57.80
10Day EMA
57.60
12Day EMA
57.70
20Day EMA
58.70
26Day EMA
59.30
50Day EMA
60.10
100Day EMA
58.40
200Day EMA
53.60
5Day SMA
56.50
10Day SMA
56.50
20Day SMA
58.80
30Day SMA
60.90
50Day SMA
61.90
100Day SMA
58.10
150Day SMA
54.60
200Day SMA
54.10
Delivery & Volume
Day
Combined Delivery Volume- 180119 Rs
NSE+BSE Traded Volume- 258555 Rs

Week
Combined Delivery Volume- 107613 Rs
NSE+BSE Traded Volume- 152136 Rs

Month
Combined Delivery Volume- 101028 Rs
NSE+BSE Traded Volume- 141810 Rs

Resistance & Support
60.19
Pivot
Resistance
First Resistance
62.92
Second Resistance
65.44
Third Resistance
68.17
Support
First Support
57.67
Second support
54.94
Third Support
52.42
Relative Strength Index
52.31
Money Flow Index
37.29
MACD
-1.60
MACD Signal
-1.84
Average True Range
3.53
Average Directional Index
24.69
Rate of Change (21)
-7.69
Rate of Change (125)
19.48

Ambalal Sarabhai Enterprises Ltd Company background

Founded in: 1977
Managing director: Mohal Kartikeya Sarabhai
Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multidimensional businesses. Each subsidiary is a distinct entity contributing its unique expertise and capabilities. It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally. ASEs strength is to lead with cutting edge technology by creating strategic technology tieups and collaborative partnerships through our broad national and international networksThe Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments. It operates in two segments, pharmaceuticals and electronics. Pharmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services. In the year 1994, the company entered into a technical collaboration with Biobras, Brazil, to manufacture highly purified insulin injections. During the year 199798, the company formed a joint venture company, namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company. During the year 199899, the company signed agreement with B V Chiron, Netherlands for introducing their anticancer drugs in India.During the year 19992000, the company entered into an MoU for marketing of products of Oncology products of Chiron Corporation, USA. The Product Division essentially comprising of Sarabai Chemicals Products was transferred to the joint venture company, Sarabhai Piramal Pharmaceuticals Ltd. In September 2008, the company acquired the manufacturing and marketing company, namely Suvik Hitek Pvt. Ltd. The Ethical Division relaunched the products of Suvik and Sarabhai Chemicals in market. Also, the company acquired Systronics (India) Pvt Ltd. During the year 200809, the Oncology Division launched two new products viz. Fludagem Xtinib. Also, the company promoted a company viz. Vovanties Laboratories Pvt Ltd, a pharmaceutical specialist with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent Drug Delivery System. During the year 201011, the Company had transferred and assigned as going concern, the business undertaking of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and Electronics Division comprising of Systronics, Teleradand SERC to Systronics (India) Ltd with effect from October 01, 2010.Sarabhai M Chemicals Ltd, a wholly owned subsidiary company started its Vitamin C coated products manufacturing since August 2019.In June 2023, Asence Pharma Pvt., Ltd. a subsidiary of the Company commenced its new oncology and synthetic API plant at Ranoli, Vadodara.
Read More

Ambalal Sarabhai Enterprises Ltd FAQs

The past 1-year return of Ambalal Sarabhai Enterprises Ltd [AMBASARABH] share was 40.58. The Ambalal Sarabhai Enterprises Ltd [AMBASARABH] share hit a 1-year low of Rs. 35.27 and a 1-year high of Rs. 77.7.

You can easily buy Ambalal Sarabhai Enterprises Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -